We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-1.02%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
-$388M
(-3.6%)
Cap. Flow
-$87.6M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
14.73%
Holding
713
New
186
Increased
183
Reduced
156
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$120M |
| 2 |
Chord Energy
CHRD
|
+$106M |
| 3 |
Electronic Arts
EA
|
+$96.9M |
| 4 |
Quest Diagnostics
DGX
|
+$89.2M |
| 5 |
Sensata Technologies
ST
|
+$76.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$138M |
| 2 |
Avnet
AVT
|
+$130M |
| 3 |
ERF
Enerplus Corporation
ERF
|
+$110M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$73.5M |
| 5 |
Honeywell
HON
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.43% |
| 2 | Technology | 19.78% |
| 3 | Energy | 7.84% |
| 4 | Industrials | 7.21% |
| 5 | Financials | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNPR
251
DELISTED
Juniper Networks
JNPR
| $9.65M | 0.09% |
+264,802
| New | +$9.41M |
|
252
DexCom
DXCM
$32.9B
| $9.5M | 0.09% |
83,798
-138,996
| -62% | -$17.6M |
|
253
Globus Medical
GMED
$11.1B
| $9.49M | 0.09% |
+138,528
| New | +$8.28M |
|
254
Viatris
VTRS
$20.5B
| $9.46M | 0.09% |
889,500
| – | – |
|
255
Jasper Therapeutics
JSPR
$20.2M
| $9.4M | 0.09% |
413,940
+34,694
| +9% | +$832K |
|
256
Immunocore
IMCR
$1.65B
| $9.29M | 0.09% |
274,038
| – | – |
|
257
NewAmsterdam Pharma
NAMS
$3.21B
| $9.29M | 0.09% |
+483,388
| New | +$9.7M |
|
258
Olema Pharmaceuticals
OLMA
$985M
| $9.22M | 0.09% |
852,554
+102,275
| +14% | +$1.11M |
|
259
Crown Holdings
CCK
$13B
| $9.18M | 0.09% |
123,350
-172,287
| -58% | -$13.9M |
|
260
Silicon Laboratories
SLAB
$7.19B
| $9.06M | 0.09% |
+81,886
| New | +$10.1M |
|
261
BioNTech
BNTX
$23.3B
| $9.04M | 0.09% |
112,538
+57,803
| +106% | +$5.28M |
|
262
Larimar Therapeutics
LRMR
$413M
| $9.01M | 0.09% |
1,242,585
+92,252
| +8% | +$707K |
|
|
FYBR
263
DELISTED
Frontier Communications
FYBR
| $8.9M | 0.08% |
+339,832
| New | +$8.46M |
|
264
Graco
GGG
$13B
| $8.84M | 0.08% |
+111,534
| New | +$9.33M |
|
|
SLRN
265
DELISTED
ACELYRIN
SLRN
| $8.75M | 0.08% |
1,984,810
+963,606
| +94% | +$4.52M |
|
266
Chewy
CHWY
$9.4B
| $8.69M | 0.08% |
+318,889
| New | +$6.07M |
|
|
RCM
267
DELISTED
R1 RCM Inc. Common Stock
RCM
| $8.68M | 0.08% |
691,442
+81,220
| +13% | +$1.01M |
|
268
D.R. Horton
DHI
$41B
| $8.66M | 0.08% |
+61,468
| New | +$9.03M |
|
269
W.W. Grainger
GWW
$64.7B
| $8.61M | 0.08% |
+9,547
| New | +$8.98M |
|
270
Elanco Animal Health
ELAN
$12.8B
| $8.59M | 0.08% |
+594,979
| New | +$9.51M |
|
271
Union Pacific
UNP
$173B
| $8.53M | 0.08% |
37,706
-72,207
| -66% | -$16.9M |
|
272
RadNet
RDNT
$5.25B
| $8.46M | 0.08% |
143,612
-54,097
| -27% | -$2.94M |
|
273
Walt Disney
DIS
$170B
| $8.44M | 0.08% |
84,974
-51,847
| -38% | -$5.58M |
|
274
Amneal Pharmaceuticals
AMRX
$6.02B
| $8.35M | 0.08% |
1,315,023
+626,917
| +91% | +$3.98M |
|
275
Toll Brothers
TOL
$14.1B
| $8.33M | 0.08% |
+72,302
| New | +$8.75M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Woodline Partners held 713 positions worth $10.5B, down 3.6% from $10.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners's Q2 2024 filing shows 186 new, 183 increased, 156 reduced and 168 closed positions. Its largest new stake was Marsh: 585,204 shares worth $123M. The largest sale was Analog Devices, an estimated $138M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Technology and Energy.
- Woodline Partners's largest Q2 2024 buy was Marsh: 585,204 shares worth $123M.
- Woodline Partners added most to Chord Energy in Q2 2024, an estimated $106M increase.
- Woodline Partners's biggest Q2 2024 reduction was Avnet, cutting an estimated $130M.
- Woodline Partners fully exited Analog Devices in Q2 2024, selling an estimated $138M.
- Woodline Partners's ten largest holdings make up 15% of its $10.5B portfolio in Q2 2024.
- Woodline Partners opened 186 new positions and closed 168 in Q2 2024.
- Woodline Partners's portfolio value fell 3.6% quarter-over-quarter to $10.5B.
Based on Woodline Partners's 13F filing for Q2 2024, filed 14 Aug 2024.